Dr. Stefan Peterli

Chief Operating Officer

Founder & Managing Director Providing consulting services for custom manufacturing of APIs and intermediates under cGMP in Asia Business development agent in Europe for selected chinese and japanese companies Medicinal chemistry consuliting M&A consulting Sourcing of APIs from Asia Outsourcing of intermediates and APIs to Asia Interim Management

Responsible on group level for evaluation of new M&A targets including technical due diligence Acquisition of new manufacturing projects for the 6 production units in EU and the US

Leading business with 100 employee site specialized in highly potent active pharmaceutical ingredients as well as controlled substance manufacturing.

Managing Director of 80+ employee Swiss pharmaceutical custom manufacturing company focussed on peptide APIs and amino acid building blocks

CEO of 120 employee custom manufacturing organization located in southern Germany

Managing Director of branch office which manufactures APIs on large scale.

Member of the Executive Management team. Responsible for sales volume of EUR 60+ mio. with a team of 8 direct reports, 3 indirect reports and several agents selling APIs mainly in the generic market. Involved in strategic decisions (expansion, M&A).

Member of the executive management team. Leading a sales team of 8 people. Responsible for global sales of EUR 100+ mio.

Responsible for Sales & Business Development in Portugal, Spain, Italy and Israel as well as selected key accounts in Germany and Switzerland.

Responsible for sales & business development for Lonza Custom Manufacturing for Germany and Switzerland. Represented wide field of technologies (ISO and GMP chemistry, microbial and mammlian fermentation, peptides).

World wide business development for Lonza Organic Fine & Performance Chemicals with a team of 6 business development managers.

Responsible for business development in the japanese market.

Supervised and coached a group of 5 project managers in custom manufacturing.

Key account manager & project leader responsible for clients in BE, DK, US, JPN. Director Marketing & Sales Japan Director Marketing & Sales US

Responsible for R&D and manufacturing incl. analytics and logistics.

Set up sales office in Cambridge, MA.

Responsible for R&D and manufacturing of APIs under cGMP. Manufactured analytical reference standards for narcotics.

Fmoc solid-phase peptide synthesis of antibiotic peptides for coupling to Vancomycin

with Prof. Dr. Henry Rapoport Process research, optimization and scale-up of novel synthesis route to the aglycone fo the natural product Staurosporine.

Design, synthesis and biological evaluation of EGF-R PRK inhibitors (anti-cancer).